Pain Management in Brugada Syndrome: A Case Report and Review

A A Pract. 2025 Jan 6;19(1):e01882. doi: 10.1213/XAA.0000000000001882. eCollection 2025 Jan 1.

Abstract

Brugada syndrome is a rare condition that increases the risk of life-threatening arrhythmias. Although there are existing anesthesia recommendations for patients with Brugada syndrome, guidance on pain management is limited. We present a novel approach to pain management in these patients, illustrated by the case of a young woman with Brugada syndrome who underwent ropivacaine peripheral nerve infusion and intravenous ketamine infusion for acute-on-chronic left upper limb pain. She received perioperative multimodal analgesia, which included neuropathic agents (pregabalin, duloxetine), and opioids (morphine, codeine). Our findings contribute to a greater understanding of safe analgesic practices for patients with Brugada syndrome.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Amides / administration & dosage
  • Amides / therapeutic use
  • Analgesics / administration & dosage
  • Analgesics / therapeutic use
  • Analgesics, Opioid / administration & dosage
  • Analgesics, Opioid / therapeutic use
  • Brugada Syndrome*
  • Female
  • Humans
  • Ketamine / administration & dosage
  • Ketamine / therapeutic use
  • Pain Management* / methods
  • Ropivacaine / administration & dosage

Substances

  • Ketamine
  • Ropivacaine
  • Amides
  • Analgesics
  • Analgesics, Opioid